EVac 70 XTRA with Integrated Cable and PROcise EZ View with Integrated Cable Product Usage: P...
FDA Device Recall #Z-2105-2015 — Class II — June 2, 2015
Recall Summary
| Recall Number | Z-2105-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 2, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | ArthroCare Corporation |
| Location | Austin, TX |
| Product Type | Devices |
| Quantity | 733 devices |
Product Description
EVac 70 XTRA with Integrated Cable and PROcise EZ View with Integrated Cable Product Usage: PLASMA WAND devices are indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT) surgery including: adenoidectomy, cysts, head, neck, oral, and sinus surgery, mastoidectomy, myringotomy with effective hemorrhage control, nasal airway obstruction be reduction of hypertrophic nasal turbinates, nasopharyngeal/laryngeal indications including tracheal procedures, laryngeal polypectomy, and laryngeal lesion debulking, neck mass, papilloma keloids, submucosal palatal shrinkage, submucosal tissue shrinkage, tonsillectomy (including palatine tonsils), traditional uvulopalatoplasty (RAUP), tumors, and tissue in the uvula/soft palate for the treatment of snoring. It is intended for procedures using a conductive media, such as normal saline or Ringers lactate.
Reason for Recall
Wands inspected with the adaptor fixture were released to the field not meeting the dielectric (Hipot) specifications.
Distribution Pattern
Worldwide Distribution - US Nationwide and the countries of Australia, Belgium, Germany, Spain, United Kingdom, Ireland, India, Italy and Singapore.
Lot / Code Information
Lot numbers 1093290 and 1091254
Other Recalls from ArthroCare Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2999-2020 | Class II | Speed Stitch Needle Cassette | Aug 17, 2020 |
| Z-3000-2020 | Class II | Smith&Nephew SmartStitch PerfectPasser Connecto... | Feb 21, 2019 |
| Z-1321-2016 | Class II | TOPAZ MicroDebrider 0.8 mm REF AC4040-01; TOPAZ... | Mar 3, 2016 |
| Z-0623-2016 | Class II | Cavity 8 Gauge Spine Wand indicated for resecti... | Oct 26, 2015 |
Frequently Asked Questions
Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.